Contrast Media Global Market Projected to Grow Radiantly by 2030; Asserts MRFR Unleashing Industry Forecast

Contrast Media Market is predicted to reach USD 4.2 billion at a CAGR of 4.01% during the forecast period:

Market Research Future (MRFR) has published a cooked research report on the “Global Contrast Media Market” that contains information from 2022 to 2030. The Contrast Media market is estimated to register a CAGR of 4.01% during the forecast period of 2023 to 2030.

MRFR recognizes the following companies as the key players in the global Contrast Media market— Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.).

Market Highlights

The global Contrast Media market is accounted to register a CAGR of 4.01% during the forecast period and is estimated to reach USD 4.2 billion by 2030.

The contrast media market refers to the sector that deals with substances used in medical imaging to enhance the visibility of specific organs, tissues, or blood vessels. These contrast agents are administered to patients before imaging procedures such as X-rays, CT scans, or MRIs to improve the clarity and accuracy of the diagnostic images.

Segment Analysis

The global Contrast Media market has been segmented based on Type, Form, Procedures and  Application.

On the basis of Type, the market is segmented into iodinated contrast media, gadolinium-based contrast media. Due to the widespread use of X-ray and CT procedures and the availability of non-ionically stable iodinated agents for enhanced diagnosis, the iodinated contrast agents category held the greatest market share in 2022.

Based on Form, the global Contrast Media market has been segmented into liquid, tablet, powder, and paste. The target audience prefers all these forms according to the requirements of the product.

Based on Procedures, the global Contrast Media market has been segmented into X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI). These include the X-ray/CT contrast agents, which aid in creating high-resolution 3D images of structures. X-ray and C.T. techniques employ barium- and iodinated-based contrast ants. When supplied or injected into the body, barium and iodine contrast agents prevent X-rays from passing through and instead block them.

Based on Application, global Contrast Media market has been segmented into cardiovascular disease, oncology, and gastrointestinal disorders. The market share leader is the fertiliser category. During the forecast period, the cardiovascular diseases (CVD) segment is anticipated to contribute significantly to revenue. This is a result of cardiovascular disorders becoming more commonplace in the world.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Contrast Media Market Research Report

Regional Analysis

The global Contrast Media market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Contrast Media market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Contrast Media market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Contrast Media market comprises of Middle East, Africa, and Latin America.

The North America Contrast Media Market dominated this market in 2022. It is anticipated to grow at a considerable CAGR during the study period, reaching USD 1.4 billion in 2022. Due to several strategic initiatives taken by leading manufacturers to target this segment's unique patient subsets, the market expansion is anticipated to pick up speed.

Additionally, the second-largest market share for Contrast Media is held by European. The region's growing market revenue, increased number of medical device businesses, and rising healthcare spending all contribute to an increase in product demand. Additionally, in the European region, the contrast media market in the UK had the biggest market share while the contrast media market in Germany had the quickest rate of growth

Moreover, In 2022, a sizable portion will come from the market for contrast media in the Asia Pacific region. This can be ascribed to the region's long-standing domestic and international manufacturers. For instance, one of the largest production facilities for contrast agents for G.E. Healthcare is located at G.E. Pharmaceuticals (Shanghai) Co., Ltd., a division of G.E. in China for diagnostic pharmaceuticals (CT/MR contrast agents). This element is anticipated to continue to fuel regional market expansion. India was the country in the region with the greatest rate of market growth, and China had the largest market share for contrast media.

Key Findings of the Study

·         The global Contrast Media market is expected to reach USD 4.2 billion by 2030, at a CAGR of 4.01% during the forecast period.

·         The North America Contrast Media Market dominated this market in 2022. It is anticipated to grow at a considerable CAGR during the study period, reaching USD 1.4 billion in 2022.

·         Based on Form, The target audience prefers all these forms according to the requirements of the product.

·         Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.).